GMO opponents worry Big Six ag companies monopolize global food supply

GMOBigSix

What the next chapter in the evolution of agriculture has produced, is something akin to the pharmaceuticalization of food. Six multinational companies — Monsanto, DuPont, Bayer, BASF, Syngenta and the Dow Chemical Co. — control the rapidly growing GMO market. And, like their Big Pharma counterparts, these multibillion-dollar companies have been accused of bullying and/or lobbying anyone that gets in the way.

Monsanto, for one, has sued some 100 farmers for patent infringement, winning judgments against farmers found to have made use of the company’s genetically engineered (GE) seed without paying required royalties, according to a 2013 Reuters story.

Some GMO opponents are concerned the Big Six are positioning themselves to monopolize the world’s food supply. They worry that the companies’ vast wealth and power — like that wielded by the pharmaceutical industry — will lead to favoritism and laws designed to protect Big Ag over organic and conventional farmers.

These opponents have legitimate reasons to be concerned. In a political system where important decisions about regulating the food supply are largely made by power players rotating through the revolving door that separates government and the private sector, it’s difficult not to be cynical.

Read full, original article: Are GMOs Safe?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.